Bioelectric Impedance Analysis in COVID-19 positive patients. A prospective prevalence study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24463

Enrollment

150

Registered

2020-04-21

Start date

2020-04-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV-2

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age = 18 years 2. SARS-CoV-2 positive (PCR or radiological diagnosis) 3. Informed consent by patient / or legal representative

Exclusion criteria

Exclusion criteria: 1. Pregnant patients. 2. Patients with electrical implants such as a pacemaker or ICD. 3. Patients who cannot maintain posture for the (10-15 min) duration of the measurement.

Design outcomes

Primary

Measure	Time frame
To measure body composition and specifically fat percentage and localisation in SARS-CoV-2 positive patients	—

Secondary

Measure	Time frame
- To gain insight into the prevalence of sarcopenic obesity amongst SARS-CoV-2 positive patients. - To assess a possible relation between the measured phase angle and severity of disease. - To compare fat percentage and localisation between SARS-CoV-2 positive patients with severe course of disease (i.e. leading to ICU admission or in-ward mortality) and those with milder course of disease (i.e. ward-to-home discharge).	—

Measure

Time frame

- To gain insight into the prevalence of sarcopenic obesity amongst SARS-CoV-2 positive patients. - To assess a possible relation between the measured phase angle and severity of disease. - To compare fat percentage and localisation between SARS-CoV-2 positive patients with severe course of disease (i.e. leading to ICU admission or in-ward mortality) and those with milder course of disease (i.e. ward-to-home discharge).

—

Contacts

Public ContactHanneke Moonen

Ziekenhuis Gelderse Vallei

moonenh@zgv.nl0318434119

Outcome results